MPW vs REGN · rev $995.5M vs P/E 14, rev $14.34B
Medical Properties Trust Inc (MPW) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Medical Properties Trust Inc (MPW) is a reit - healthcare facilities company listed on US.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported MPW revenue for 2024-12-31 was $995.5M. Net income was -$2.41B. Revenue was up 14.2% from 2023-12-31 to 2024-12-31. MPW currently screens at market cap $3.02B.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
MPW currently screens at market cap $3.02B. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the MPW and REGN stock pages for the full models.
Not investment advice.